View Author
patient myeloma level factor activity treatment thalidomide plasma study coagulation myeloma patients chemotherapy venou thrombosis induction blood incidence venous thrombosis dexamethasone protein therapy venous thromboembolism fviii induction treatment tissue plasma ct activity chapter group abnormality disease mm patients willebrand prothrombotic coagulation abnormalities assay barlogie b thromboembolism von willebrand factor combination mp-tf coagulation abnormalities increase stage thromb regimen resistance control auwerda disorder multi-agent chemotherapy mp-tf activity complication cancer effect result mp-tf activity levels melphalan prothrombotic protein c induction chemotherapy amyloidosi fibrinogen anaissie e bortezomib haemost range barlogie table analysis induction therapy macrophage storage phase thrombotic cell transplantation antibody starch doxorubicin protein c resistance zangari platelet
4 Most Recent Publications
|
Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma
(Article)
Auwerda, J.J.A. Yuana, Y. Osanto, S. Maat, M.P.M. de Sonneveld, P. Bertina, R.M. Leebeek, F.W.G. |
2011-01-01
|
|
Acquired Coagulation Abnormalities and Thrombosis in Multiple Myeloma
(Doctoral Thesis)
Auwerda, J.J.A. |
2008-12-18
|
|
Prospective evaluation of coagulopathy in multiple myeloma patients before, during and after various chemotherapeutic regimens
(Article)
Marion, A.M.W. van Auwerda, J.J.A. Lisman, T. Sonneveld, P. Maat, M.P.M. de Lokhorst, H.M. Leebeek, F.W.G. |
2008-07-01
|
|
Prothrombotic coagulation abnormalities in patients with paraprotein-producing B-cell disorders
(Article)
Auwerda, J.J.A. Sonneveld, P. Maat, M.P.M. de Leebeek, F.W.G. |
2007-07-01
|
